ARM

Direct agentic AI product headline (Metis security) is exactly the catalyst pattern we want, but thesis_pct=51 and win_prob=60 both miss the 60/65 convergence bar. PE 356 and extreme momentum suggest late entry. Skip - chase risk too high without thesis support.

Fails convergence bar decisively: thesis_pct 51 and win_prob 60 both below threshold. PE 356 is extreme, risk_quality 15 is the weakest in the batch. Catalysts are all indirect (ARM-based chips in others' deals). Momentum-only setup near ATH with stretched valuation — this is the late-stage chase that ends badly. Skip.

ARM has a direct product validation catalyst (NVIDIA Vera CPU with Olympus cores) and strong momentum, but thesis percentile is only 51 and win-prob 60 — fails the convergence bar (need both >=60/>=65) for new buy. Valuation extreme even by AI standards. Stay on watchlist.

Fails new-buy convergence bar decisively: thesis_pct=51 below 60 floor, win_prob=60 below 65 floor. Momentum is the only standout but PE 356 and lowest risk_quality in batch suggest most of the move is priced in. Indirect catalyst only. Hard skip.

ARM fails the convergence bar (thesis 51, win_prob 60 — both below threshold). Momentum is extreme but valuation is stretched and catalyst is indirect (ARM benefits tangentially from ASIC thesis). No held position to protect. Skip — would chase momentum at extreme multiples without thesis support.

ARM has a screaming catalyst (5x profit growth headline, ATH) and momentum, but win_probability at 44 and risk_quality at 15 are disqualifying for new_buy. Thesis only 51. The -8.5% 5-day pullback signals momentum deterioration despite the headline. Even with the ARM-specific learning adjustment, the convergence bar isn't met. Skip but keep on radar.

Named agentic AI partnership headline (ARM/Red Hat) is exactly the catalyst pattern our learnings flagged. However, win_probability=44 is far below the 65 convergence bar, and recent -8.46% 5d move and PE 243x indicate genuine deterioration, not just valuation worry. Catalyst alone doesn't override broken near-term setup. Skip but track.

ARM fails the new_buy convergence bar on both axes — thesis only 51, win-prob only 44. Despite near-highs and momentum scores, recent 5d down -8.46% shows the breakout is cracking. Extreme valuation, lowest risk-quality in batch. Skip cleanly.

Despite the headline-perfect agentic-AI catalyst, ARM fails the convergence bar badly: win_prob 44 and thesis 51 are both well below 60/65 thresholds. Recent -8.46% 5d move and extreme PE compound the risk. Catalyst alone doesn't override broken win-prob per core principle 5. Skip.

ARM fails convergence bar decisively: win_prob 44, thesis only 51, recent sharp selldown (-8.46% 5d), PE 243x, risk_quality 15. No direct catalyst. Three of four specialists are skeptical. Hard skip — would be quality-deteriorating add to an already concentrated chip book.

Watchlist name failing convergence test - thesis_pct only 51 and win_probability 44, well below 60/65 bar. Recent sharp selling and 243x PE with deteriorating momentum. Even with structural ARM ecosystem tailwinds, no reason to initiate here. Skip.

ARM fails the new_buy convergence bar on both thesis (51) and win_probability (44). Sharp recent selling, extreme valuation, and momentum deterioration all argue against entry despite the Huawei Armv9 catalyst. Skip.

Thesis and win_prob both ~50, no ARM-specific news, extreme valuation, and would add correlated sector risk. Fails new_buy convergence on both axes. Hard skip.

ARM fails the convergence bar: thesis 51 and win-prob 50 both mediocre, PE 250x, no ticker-specific catalyst, 11% off highs (not a breakout). Only sector tailwinds support it. Skip in favor of cleaner setups already held.

ARM fails the new-buy convergence bar: thesis 51 and win-prob 50 both below thresholds, no breakout (11% below highs), extreme valuation with no specific catalyst. Generic sector tailwind isn't enough. Skip.

Watchlist name fails convergence test: thesis_pct=51 and win_prob=50 both below new_buy bar (60/65). Stock is 11% off highs so the breakout-confirmation override doesn't apply. Extreme PE 250x with mediocre conviction signals = pass. Catalyst is real but not enough to override weak setup.

ARM lacks the convergence bar — thesis 51 and win_prob 50 both well below the 60/65 threshold for new buys. Extreme valuation with no clear near-term catalyst beyond a tangentially-related CPU article. Risk quality 15 and sector concentration both veto. Skip.

ARM fails convergence on multiple fronts: thesis_pct=51 and win_prob=50 are both below the 60/65 new-buy bar. Risk quality at 15 is alarming, extreme valuation with no breakout to justify it (11% below highs, flat 5d). Sector concentration also blocks. Unlike AMD this isn't a learned-pattern miss — the technical setup isn't there. Skip clearly.

ARM fails the new_buy convergence bar on both axes (thesis 51 < 60, win_prob 50 < 65). PE 250x with flat momentum and 11% below highs means no breakout signal to override valuation concern. Adds to already heavy semi concentration with high correlation. Clear skip — weakest stock in the batch.

Watchlist name failing the convergence bar (thesis 51, win-prob 55 both well below 60/65). Extreme valuation, off the highs unlike AMD, and would worsen sector concentration. Clear skip and the weakest name in this batch.

Direct positive catalyst and strong performance, but thesis_pct only 51 and win_probability 55 — fails new-buy convergence bar (need thesis>=60 AND WP>=65). Valuation is the problem: 277x PE with stock 11% off highs after a moonshot already. Risk quality 15 is lowest in batch and would compound chip concentration. Skip.

Fails new-buy convergence bar (thesis 51 < 60, win_prob 55 < 65). Risk quality at 15 is alarming, valuation extreme, only indirect catalyst exposure. Sector concentration also blocks. No reason to own here.

Strong catalyst and momentum, but win_probability only 55, thesis_pct=51, extreme valuation, and stock already pulled back 11% from highs. Fails new_buy convergence bar (need thesis>=60 AND WP>=65). Hard sector concentration constraint also blocks. Skip.

ARM fails new-buy convergence bar (thesis_pct=51 < 60, win_probability=55 < 65). Extreme valuation, off the highs, and would worsen sector concentration. Catalyst is only indirect ecosystem tailwind. Hard skip.

Fails new_buy convergence test: thesis (51) and win-prob (55) both below thresholds. Extreme PE of 277x with limited margin for error, plus Risk Agent flags concentration and volatility. No reason to add to watchlist conviction here. Hard skip.

ARM fails the new_buy convergence test (thesis 51, win_prob 55 — both below thresholds). Risk quality is 15 (worst in batch), valuation at 277x PE leaves no room for error, and adding would worsen ai-chips concentration. Stock has already run from $100 to $211 with most upside captured. Hard skip.

Strong catalyst (Meta/Graviton validates ARM architecture) but Win-Probability is below threshold and valuation is extreme. Fails convergence test for new buy (thesis=51, win_prob=45). Catalyst drives urgency, not direction — and the direction here is mean reversion risk after parabolic move. Skip.

ARM fails convergence on both axes (thesis 51, win_prob 45). Win-Probability agent explicitly warns of mean reversion after parabolic 14.76% 5d surge at extreme PE of 313. Risk agent flags volatility and concentration. No reason to chase. Skip.

Watchlist name failing new-buy convergence on both axes: thesis_pct=51 below 60, Win-Probability=45 well below 65. Risk Agent flags multiple concerns including extreme volatility and concentration. Worst risk-adjusted setup in the batch — hard skip.

Clear skip. Watchlist name with win_probability of 45 — fails convergence test outright. Specialists flag mean-reversion risk after 14.76% 5d surge, PE of 313, and the position would worsen already-elevated ai-chips concentration. Risk_quality 15 is the lowest in batch. No entry justification.

Fails new-buy gate decisively (win_prob 45 << 65). Win-Prob agent explicitly calls out downside risk after the +14.8% 5d surge with PE 313. Risk agent flags concentration, volatility, and correlation. Hard skip.

Hard skip. Win-probability 45 well below the 65 new-buy threshold, valuation extreme, stock already extended at ATH after parabolic move, and would worsen ai-chips concentration. No convergence — thesis is only 54 anyway. Worst risk/reward in the batch.

Fails convergence test badly (win_prob 45 < 65). Win-Prob agent explicitly warns of mean reversion from parabolic move, PE 313 leaves no margin. Risk agent flags concentration AND volatility AND correlation. Catalyst alone cannot override broken win-probability. Hard skip.

Exceptional catalyst but win-probability of 30 fails the convergence bar for new buys. Risk agent gives lowest score in batch (15) citing extreme valuation and concentration. Catalyst drives urgency, not direction — and direction here is poor entry timing. Skip.

Fails new-buy convergence test on both thesis (54) and win_prob (30). Catalyst is genuinely strong (Meta Graviton/ARM IP) but catalyst alone doesn't override broken valuation and concentration risk. Skip.

Watchlist name failing convergence (win_prob=30, well below 65). Risk Agent gives lowest quality score in batch (15) with multiple flags. Even with supportive agentic AI catalysts, extreme valuation post-11.5% surge and binding ai-chips concentration limit make this a hard skip per Principle 3 and 5.

Fails new-buy convergence (win_prob=30 vs 65 bar; thesis=54 vs 60 bar). Risk agent flags extreme volatility, concentration, and correlation. 11.5% 5-day spike to ATHs sets up consolidation risk. Hard skip.

Fails both legs of the new-buy test — thesis 54 and win-prob 30 both below thresholds. Buying an 11% 5-day surge into a 260 PE with sector already overweight is precisely what investors scrutinize. Clean skip.